Point of Care Diagnostics market is expected to reach US$ 105.22 billion by 2033 from US$ 50.08 billion in 2024, with a CAGR of 8.60% from 2025 to 2033. Some of the major reasons propelling the market include the growing need for quicker and more convenient diagnostic solutions, the global rise in infectious disease prevalence, and technological and miniaturization improvements.